Cargando…

Premarket Approval Through the 510(k) Process: Lessons from the Translation Process of Magnetic Resonance Elastography

Detalles Bibliográficos
Autores principales:	Aponte Ortiz, Jaime A., Konik, Ewa, Eckert, Elizabeth C., Pepin, Kay M., Greenberg‐Worisek, Alexandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132361/ https://www.ncbi.nlm.nih.gov/pubmed/29969182 http://dx.doi.org/10.1111/cts.12581

Ejemplares similares

Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017
por: Dubin, Jonathan R., et al.
Publicado: (2021)

Diagnostic Testing for Zika: Observing Rapid Translation During a Public Health Emergency
por: Kurani, Shaheen, et al.
Publicado: (2017)

Fecal Microbiota Transplantation: An Ambiguous Translational Pathway for a Promising Treatment
por: Joseph, Josiane, et al.
Publicado: (2019)

Overview of the Premarketing and Postmarketing Requirements for Drugs Granted Japanese Conditional Marketing Approval
por: Matsushita, Shunsuke, et al.
Publicado: (2021)

Navigating the Clinical Translation of Medical Devices: The Case of Radiofrequency Ablation
por: Armaiz Flores, Abdel, et al.
Publicado: (2017)

Chimeric Antigen Receptor T‐Cells: Successful Translation of the First Cell and Gene Therapy From Bench to Bedside
por: Rodriguez‐Cartagena, Luis G., et al.
Publicado: (2018)

Liquid Biopsy: Emergence of an Alternative Cancer Detection Method
por: Law, Ethan W., et al.
Publicado: (2020)

Quantification of US Food and Drug Administration Premarket Approval Statements for High-Risk Medical Devices With Pediatric Age Indications
por: Lee, Samuel J., et al.
Publicado: (2021)

Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports
por: Chang, Lee, et al.
Publicado: (2015)

Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011
por: Rathi, Vinay K., et al.
Publicado: (2020)

Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
por: Rathi, Vinay K, et al.
Publicado: (2023)

Cardiovascular Safety Profile of Dapoxetine during the Premarketing Evaluation
por: Kowey, Peter R., et al.
Publicado: (2012)

Premarket Safety and Efficacy Studies for ADHD Medications in Children
por: Bourgeois, Florence T., et al.
Publicado: (2014)

Assessing Visual Outcomes: A Comparative Study of US-FDA Premarket Approval Data for Multifocal and EDOF Lens Implants in Cataract Surgery
por: Moshirfar, Majid, et al.
Publicado: (2023)

Artificial Intelligence in Radiology: A Call for Thoughtful Application
por: Driver, C. Noelle, et al.
Publicado: (2019)

Toward Soluble 5,10-Diheterotruxenes: Synthesis and Reactivity of 5,10-Dioxatruxenes, 5,10-Dithiatruxenes, and 5,10-Diazatruxenes
por: Górski, Krzysztof, et al.
Publicado: (2020)

Left to Their Own Devices: Breakdowns in United States Medical Device Premarket Review
por: Hines, Jonas Zajac, et al.
Publicado: (2010)

United States Food and Drug Administration’s 510(k) Pathway: Drawing Implications from the Approvals of Brachytherapy Devices
por: Wang, Sophie, et al.
Publicado: (2019)

The current landscape of the FDA approved companion diagnostics
por: Jørgensen, Jan Trøst
Publicado: (2021)

Ultra‐processed foods: Processing versus formulation
por: Levine, Allen S., et al.
Publicado: (2023)

First vaccine approval under the FDA Animal Rule
por: Beasley, David W C, et al.
Publicado: (2016)

Quality by Design risk assessments supporting approved antibody products
por: Kelley, Brian
Publicado: (2016)

Challenges and opportunities for improving access to approved neonatal drugs and devices
por: Lewis, Tamorah, et al.
Publicado: (2022)

The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDA.
por: Olivier, Timothée, et al.
Publicado: (2022)

Fast Methods for Drug Approval: Research Perspectives for Pandemic Preparedness
por: Abdin, Ahmad Yaman, et al.
Publicado: (2023)

Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics
por: Varma, Tanvee, et al.
Publicado: (2021)

Translating Genetic Discovery into a Mechanistic Understanding of Pediatric Movement Disorders: Lessons from Genetic Dystonias and Related Disorders
por: Lin, Wei‐Sheng
Publicado: (2022)

An open science pathway for drug marketing authorization—Registered drug approval
por: Naudet, Florian, et al.
Publicado: (2021)

Japan's COVID‐19 treatment strategy: An examination of approved oral medications
por: Higuchi, Yuka, et al.
Publicado: (2023)

3017 Regulatory Science in Translational and Regenerative Medicine Biomedical Education: A Pilot Course
por: Greenberg-Worisek, Alexandra Joelle, et al.
Publicado: (2019)

Exploring Gender Differences in Student Evaluations of Faculty in a Graduate Clinical Translational Research Program
por: Greenberg-Worisek, Alexandra J, et al.
Publicado: (2020)

Antioxidants, Food Processing and Health
por: Poljsak, Borut, et al.
Publicado: (2021)

Time Series Analysis of the Effectiveness and Safety of Capsule Endoscopy between the Premarketing and Postmarketing Settings: A Meta-Analysis
por: Iijima, Kazuo, et al.
Publicado: (2016)

Premarket Development Times for Innovative Vaccines––To What Extent Are the Coronavirus Disease 2019 (COVID-19) Vaccines Outliers?
por: Beall, Reed F, et al.
Publicado: (2021)

The FDA-Approved Essure Device Counseling Order Fails to Promote Patient Empowerment
por: Gunn, Christine M., et al.
Publicado: (2019)

A Patient‐Centric Model for Discontinuation of a Single‐Sourced Approved Drug
por: Caplan, Arthur, et al.
Publicado: (2019)

Conditional early approval for new drug applications in Japan: Current and emerging issues
por: Tanaka, Mototsugu, et al.
Publicado: (2023)

Identification of predicate creep under the 510(k) process: A case study of a robotic surgical device
por: Lefkovich, Charlotte, et al.
Publicado: (2023)

An insider's perspective on FDA approval of aducanumab
por: Wang, Yaning
Publicado: (2023)

Abstract QS26: A Prospective Pilot Study of Robotic-Assisted Harvest of the Latissmus Dorsi Muscle for FDA 510(K) Approval
por: Shuck, John, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_igsj4n6fa8qfqihsb02cg0op15